American teens are increasingly turning to the weight-loss drug Wegovy as more families and their doctors gain confidence in its use for young people with obesity, new data shared with Reuters shows.

One such trial is assessing whether semaglutide, the main ingredient for the weight loss and diabetes drugs Ozempic and Wegovy, can slow the progression of dementia. An estimated 982,000 people ...

Investing.com -- The use of the weight-loss drug Wegovy among American teenagers has seen a significant rise, according to new data analyzed by Reuters. The data shows that the average rate of ...

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) announced on Monday that its experimental drug, when combined with Novo Nordisk’s popular obesity medication Wegovy, helped patients preserve up to ...

New data indicates that American teenagers are increasingly using the weight-loss drug Wegovy, as confidence in its use for young people with obesity grows among families and doctors. According to ...

Some people see results in the first weeks of use Factors like metabolism and lifestyle habits can affect how they work Following a healthy diet and exercise can speed up results Some people see ...

Oh-oh-oh Ozempic, you know it's not the only weight loss injectable that's got people talking these days. Roughly three years ago we were still figuring out why exactly a large chunk of the Real ...

Amid the rising demand for effective weight management solutions, prescription medications such as Wegovy and Ozempic have gained quite a bit of attention for their potential to manage type 2 ...

Hims & Hers Health, Inc. HIMS announced that eligible customers can now access six months of prescription-only Wegovy at a new, affordable price. The company, via this offer, aims to make proven ...

Danish drugmaker Novo Nordisk A/S is preparing to launch its blockbuster weight-loss drug Wegovy in India within the next several weeks, sources told Moneycontrol. The move thrusts the company ...